AN OVERVIEW ON SYMPTOMS CAUSES TEST TREATMENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE 

Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2012, Vol 3, Issue 1

Abstract

Chronic obstructive pulmonary disease (COPD) has a dramatic effect on quality of life. The need to formulate a different set of parameters for peoples was felt because of the differences in risk factors, disease prevalence and pattern, and above all, the different overall health-care infrastructure. Moreover a large burden of tuberculosis, which is an important cause of cough, adds to the difficulties of diagnosis and management. Worldwide, COPD ranked as the sixth leading cause of death in 1990. It is projected to be the fourth leading cause of death worldwide by 2030 due to an increase in smoking rates and demographic changes in many countries. When the damage is severe, it may become difficult to get enough oxygen into the blood and to get rid of excess carbon dioxide. These changes lead to shortness of breath and other symptoms. Unfortunately, the symptoms of chronic obstructive pulmonary disease cannot be completely eliminated with treatment and the condition usually worsens over time. However, treatment can control symptoms and can sometime slow the progression of the disease. More than 12 million people are currently diagnosed with COPD. An additional 12 million probably have the disease and don't know it. COPD has received scant attention in comparison to other respiratory conditions such as asthma and lung cancer. Respiratory physicians around the world now believe the attitude of little can done for this self inflicted disease is not justifiable. Attempts have been made to redress this deficit with the recent introduction of guidelines in the management and care of patients with COPD by both the American Thoracic Society and European Respiratory Society. So this review provides the overall knowledge about the COPD as well as their management. 

Authors and Affiliations

Shailendra Wasnik, Ashwani Patel, Seema Kohli

Keywords

Related Articles

QSAR MODELING OF GELATINASE INHIBITORS: MLR APPROACH 

Matrix metalloproteinases are regulated by growth factors, hormones, cytokines etc. and endogenous inhibitors control them. Over expression of matrix metalloproteinases can lead to a variety of pathological disorders whi...

PREVALENCE OF DIABETES MELLITUS AND OBESITY AMONG POPULATION OF SULTANPUR KUNHARI AND ITS SURROUNDING AREA, HARIDWAR UTTARAKHAND 

The burden of diabetes is to a large extent the consequence of macrovascular (coronary artery disease, peripheral vascular disease, and atherosclerosis) and microvascular (like retinopathy, neuropathy, and nephropathy) c...

SEASONAL VARIANCE ON GROUNDNUT SEED PRODUCTION: ROUND THE YEAR EXPERIENCES 

The peanut, or groundnut (Arachis hypogaea), is a species in the legume or "bean" family (Fabaceae). The peanut was probably first domesticated and cultivated in the valleys of Paraguay. The specific name, hypogaea means...

INDIGENOUS EFFECT OF CYNODON DACTYLON IN EXPERIMENTAL INDUCED ULCERS AND GASTRIC SECRETIONS 

Cynodon dactylon is a perinneal grass,the plant is a rich source of metabolites such as proteins,carbohydrates mineral constituents, β-sitosterols, flavinoids, alkaloids, glycosides and triterpenoids the plant has been l...

REVIEW ON SUBSTITUTED 1,3,4-OXADIAZOLE AND ITS BIOLOGICAL ACTIVITIES 

Oxadiazole or furadiazole is a five membered heterocyclic nucleus and is considered to be derived from furan by replacement of two methane (-CH=) group by pyridine type nitrogen. Oxadiazole is a versatile lead compound f...

Download PDF file
  • EP ID EP140273
  • DOI -
  • Views 78
  • Downloads 0

How To Cite

Shailendra Wasnik, Ashwani Patel, Seema Kohli (2012). AN OVERVIEW ON SYMPTOMS CAUSES TEST TREATMENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE . International Research Journal of Pharmacy (IRJP), 3(1), 69-76. https://europub.co.uk/articles/-A-140273